Lose 9-20% of your weight in one year.*
-p-500.webp){kind=logo}
What 9% weight loss could look like for you
*Medical treatment may not be appropriate for you even if you have a high BMI
How it works: Makes you feel fuller to control appetite.
Administration: Daily pen injection. One pen lasts a week
Safety & Side Effects: Should not be used with other liraglutide-containing products or by those with a history of certain thyroid cancers. Side effects may include gastrointestinal symptoms.
injections
are equal
with real experience
what to expect?
How the Program works?
have questions?
have questions?
from
from
Saxenda is a prescription medicine for weight management. It is prescribed for adults with excess weight or obesity, to help them lose weight and keep it off.
Saxenda works like a hormone the body produces naturally that regulates appetite, known as GLP-1, to help control hunger and manage weight.
Saxenda is injected subcutaneously, meaning under the skin, typically in the abdomen, thigh, or upper arm once daily.
Common side effects include nausea, diarrhea, constipation, vomiting, injection site reactions, and low blood sugar. More serious side effects may occur and should be discussed with a healthcare provider.
Long-term use of Saxenda, in conjunction with diet and exercise, has been associated with sustained weight loss. It may also contribute to improvements in various health indicators such as blood sugar, blood pressure, and cholesterol levels. However, like any medication, it can have side effects, and its long-term use should be regularly monitored by a healthcare provider. It's important to discuss the risks and benefits of long-term treatment with Saxenda with your healthcare provider.
- Thyroid tumors have been noted in rodent studies with Saxenda, so it should not be used in patients with a personal or family history of MTC or MEN 2.
- Pancreatitis has been reported in patients taking Saxenda. It should be discontinued if pancreatitis is suspected.
- Saxenda may cause hypoglycemia in patients with type 2 diabetes on anti-diabetic therapy.
- Personal or family history of medullary thyroid carcinoma (MTC).
- Patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Pregnancy, as weight loss offers no potential benefit during this time and can harm an unborn baby.
- Allergic reactions to liraglutide or any other components of Saxenda.
